Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Advita Ortho Introduces Axis Clinical Research Platform: As reported by OrthoSpineNews, Advita Ortho launched Axis, a surgeon-facing clinical research platform synthesizing 20+ years of multicenter shoulder arthroplasty registry data from >25,000 patients and 250+ publications to support evidence-based planning.
• Stryker Expands Foot & Ankle Ecosystem at AOFAS 2026: Featured on OrthoSpineNews, Stryker launched Prophecy® Surgical Planning for the Incompass™ Total Ankle System alongside the Hoffmann® LRF smartHEX™ circular external fixation frame.
• CurvaFix Reports Real-World Durability Across 3,800 Implants: As reported by OrthoSpineNews, real-world registry data from 3,800 CurvaFix® curved intramedullary implants placed by >200 surgeons showed an overall removal rate of 1.45% and a 0.03% in vivo breakage rate.
• L&K BIOMED BluEX Cervical Expandable Cage Cleared: L&K BIOMED Co., Ltd. received FDA 510(k) clearance (K262489) for the BluEX Cervical Expandable Cage System indicated for anterior cervical discectomy and fusion (ACDF).
• Corin Icona Hip Stem Cleared: Corin, Ltd. obtained FDA 510(k) clearance (K261576) for the Icona Hip Stem designed for primary and revision total hip arthroplasty.

DAILY ANNOUNCEMENTS BY CATEGORY

Joint Reconstruction

Advita Ortho — Advita Ortho Launches Axis Clinical Research Platform Distilling 20+ Years and 25,000 Cases of Multicenter Shoulder Evidence

• Summary: Advita Ortho announced the launch of Axis, a dedicated clinical research initiative designed to connect shoulder surgeons with an extensive multicenter clinical evidence base shaping the future of arthroplasty. Built around more than 20 years of shoulder data encompassing over 25,000 patients from 45 clinical sites worldwide, the program distills findings from more than 250 peer-reviewed studies into accessible “ORbits” summaries alongside investigator video perspectives. Advita is presenting updated research from this database at the International Congress of Shoulder and Elbow Surgery (ICSES 2026) in Vancouver, evaluating computer-assisted navigation accuracy, CT-based radiomics, and predictive clinical analytics.
• Key Details:
  • Device/System Name: Axis Clinical Research Resource & Equinoxe® Shoulder Database
  • Status: Clinical Research Platform & Multicenter Evidence Registry
  • Clinical Significance: Synthesizes robust longitudinal registry data to validate computer-assisted navigation, CT radiomic analysis, and predictive modeling for implant positioning and outcome optimization in shoulder arthroplasty.
• Original Source: OrthoSpineNews

Surgical Robotics, AI & Navigation

Stryker — Stryker Showcases Foot & Ankle Innovation at AOFAS 2026 with Prophecy Surgical Planning for Incompass Total Ankle and Hoffmann LRF smartHEX

• Summary: Stryker announced key portfolio expansions at the 2026 American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Seattle, highlighted by the integration of Prophecy® Surgical Planning with the Incompass™ Total Ankle System. Prophecy brings over 14 years and 100,000 cases of patient-specific 3D planning experience to Incompass, providing surgeons with enhanced 3D visualization and dual resect-through and pin-through fixation options. Stryker also introduced Hoffmann® LRF smartHEX™, expanding its limb reconstruction offering with modular rings, struts, a connected patient mobile app, and reimagined digital software for lower extremity deformity correction.
• Key Details:
  • Device/System Name: Prophecy® Surgical Planning for Incompass™ Total Ankle System & Hoffmann® LRF smartHEX™
  • Status: Commercial Launch / AOFAS 2026 Showcase
  • Clinical Significance: Unifies preoperative patient-specific 3D planning with intraoperative total ankle resection while streamlining complex hexapod frame planning and digital connected care for limb salvage and deformity correction.
• Original Source: OrthoSpineNews

Trauma & Extremities

CurvaFix — CurvaFix Highlights 1.45% Removal Rate Across First 3,800 Curved Pelvic Implants Ahead of OTA 2026 Meeting

• Summary: CurvaFix announced that orthopaedic trauma surgeons will present real-world clinical performance data from the first 3,800 CurvaFix® curved intramedullary implants at the 42nd Annual Orthopaedic Trauma Association (OTA) Meeting in Nashville. Across more than 200 surgeons treating fragile and high-energy pelvic ring fractures, the system demonstrated an overall removal rate of 1.45%, with specific removal causes including in vivo implant breakage (0.03%), implant backout (0.05%), and malpositioning (0.24%). The data provide strong clinical evidence supporting curved intramedullary fixation over conventional straight screws in challenging pelvic anatomy.
• Key Details:
  • Device/System Name: CurvaFix® Curved Intramedullary System
  • Status: Clinical Registry Presentation / OTA 2026
  • Clinical Significance: Validates the safety, mechanical stability, and low hardware failure rate of curved intramedullary nailing for pelvic ring fractures, mitigating screw cut-out and reoperation in osteoporotic bone.
• Original Source: OrthoSpineNews

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES — ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2–4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.